"10.1371_journal.pone.0088426","plos one","2014-02-06T00:00:00Z","Esther Rodríguez; Jaume Ferrer; Jan-Paul Zock; Ignasi Serra; Josep M Antó; Jordi de Batlle; Hans Kromhout; Roel Vermeulen; David Donaire-González; Marta Benet; Eva Balcells; Eduard Monsó; Angel Gayete; Judith Garcia-Aymerich; the PAC-COPD Study Group","Servei de Pneumologia, Hospital Universitari Vall dHebron, Universitat Autònoma de Barcelona, Barcelona, Spain; CIBER de Enfermedades Respiratorias (CIBERES). Instituto Nacional de Salud Carlos III, Madrid, Spain; Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain; Servei de Pneumologia, Hospital del Mar-IMIM, Barcelona, Spain; CIBER Epidemiologia y Salud Pública (CIBERESP). Instituto Nacional de Salud Carlos III, Madrid, Spain; Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Barcelona, Spain; Enviromental and Occupational Health Division, Institute for Risk Assessment Sciences, Utrecht, The Netherlands; Servei de Pneumologia, Hospital Universitari Parc Taulí, Sabadell, Spain; Servei de Radiologia, Hospital del Mar-IMIM, Barcelona, Spain","¶ Membership of the PAC-COPD Study Group is provided in the Acknowledgments","Jaume Ferrer has received financial support from Almirall, Glaxo Smithkline, Novartis, Menarini, Nycomed and Boehringer Ingelheim for scientific meetings, research grants, advisory boards and scientific talks. Esther Rodríguez has received financial support from Novartis for scientific meetings and talks. This study was partly funded by Novartis Farmacèutica, Spain. There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials.","2014","02","Esther Rodríguez","ER",15,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
